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ABSTRACT
The purpose of this study was to compare the efficacy of two dose levels of L-Alanyl-LGlutamine in a commercially available sports drink to the sports drink only on time to exhaustion,
neuromuscular fatigue and physiological measures during prolonged endurance exercise. Twelve
endurance-trained males (23.5±3.7 yrs; 175.5±5.4 cm; 70.7±7.6 kg) performed four trials, each
consisting of 1 hr treadmill runs at 75% of VO2peak followed by a run to exhaustion at 90% of
VO2peak. The trials differed in type of hydration. One trial consisted of no hydration (NHY),
another required ingestion of only a sports drink (ET), and two trials required ingestion of a low
dose (LD) (300 mg∙500 ml-1) and high dose (HD) of L-Alanyl-L-Glutamine (1 g∙500 ml-1) mixed
in the sports drink. During the fluid ingestion trials 250 ml were consumed every 15 min. Plasma
glutamine, glucose, electrolytes, and osmolality were measured prior to the run (PRE), and at 30,
45, and 60 min. VO2, RQ, and HR were measured every 15 min and surface electromyography
(EMG) of the vastus lateralis and rectus femoris were measured every 10 min during the 1 hr
run. Time to exhaustion was significantly longer during the LD and HD trials compared with
NHY. Plasma glutamine concentrations were significantly elevated at 45 min in LD and HD
trials, and remained elevated at 60 min during HD. Sodium concentrations increased with the
beginning of exercise and remained stable for the duration of the 1 hr run. At 60 min plasma
sodium was significantly lower in all trials compared with NHY. The results from this study
indicated that ingestion of the alanine-glutamine dipeptide at either the low or high dose
significantly improved time to exhaustion during high intensity exercise compared to a no
hydration trial. These differences were not noted between ET and NHY.
Keywords: Alanine-Glutamine, Running Performance, Electrolytes, Electromyography
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CHAPTER I
Introduction
A number of factors have been identified that can lead to fatigue during endurance
activity. These causes of fatigue range from substrate availability, electrolyte imbalance,
dehydration, hyperthermia, and neuromuscular fatigue. Dehydration often leads to a reduced
sweat rate and reduction in skin blood flow from the loss of fluid leading to an increase in core
temperature (Coyle, 1999; Coyle and Montain, 1992a, 1992b; Gonzalez-Alonso, MoraRodriguez, Below, & Coyle, 1995). These effects may be further magnified if dehydration
occurs during exercise in a hot environment. Ingestion of fluid during endurance exercise helps
maintain circulating plasma volume decreasing the cardiovascular strain and reducing the risk of
hyperthermia (Coyle and Montain, 1992a, 1992b). It has been reported that a fluid loss of
approximately 2 to 3% of body weight can impact endurance capacity (Coyle, 2004; Goulet,
2013; Montain, 2008). The reduction in plasma volume results in increased heart rate, increased
muscle glycogen use, and reduced central nervous system function (Cosgrove et al., 2014).
During prolonged endurance events (lasting longer than 1 hr) substrate availability, the
loss of fluid, increase in core temperature, and change in plasma electrolytes are major factors
leading to a decrease in exercise performance (Coyle, 1999; Sawka and Noakes, 2007). The
ingestion of fluid during prolonged endurance events has been shown to reduce the
cardiovascular strain on the individual leading to delayed fatigue (Coyle, 2004). In events
lasting less than 1 hr, the benefits of ingesting a carbohydrate solution versus a placebo appear to
be equivocal. Several studies have shown an improvement in performance (Ball, Headley,
Vanderburgh, & Smith, 1995; Below, Mora-Rodriguez, Gonzalez-Alonso, & Coyle, 1995;
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Burke, Wood, Pyne, Telford, & Saunders, 2005; Carter, Jeukendrup, Mundel, & Jones, 2003),
while others have shown no improvement (Anantaraman, Carmines, Gaesser, & Weltman, 1995;
Desbrow, Anderson, Barrett, Rao, & Hargreaves, 2004; Tsintzas, Liu, Williams, Campbell, &
Gaitanos, 1993). In addition to fluid loss through sweating, the loss of electrolytes may play a
role in the onset of fatigue during endurance exercise (Bangsbo, Gunnarsson, Wendell, Nybo, &
Thomassen, 2009; Cairns & Lindinger, 2008; Nielsen et al., 2004; Nordsborg et al., 2008).
Electrolyte loss can impact nerve impulse conduction, muscle fiber contraction, and maintenance
of cell membrane permeability (Shier, Butler, & Lewis, 2004). Studies examining electrolyte
replacement during exercise have recommended sodium be included in fluids if exercise exceeds
2 h, or for those individuals who lose more than 3 – 4 g of sodium in their sweat (Coyle, 2004;
Shirreffs and Sawka, 2011).
It is highly recommended that fluid and electrolyte replacement strategies are used to
maintain endurance performance in athletes (Sawka et al., 2007; Shirreffs and Sawka, 2011).
Recently, glutamine has been shown to enhance fluid and electrolyte absorption in both animal
(Lima et al., 2002; Silva et al, 1998) and human models (van Loon, et al., 1996). Glutamine is a
non-essential amino acid and is involved in many physiologic functions including cellular
proliferation, acid-base balance, transport of ammonia between tissues, and antioxidant synthesis
(Curi et al., 2005; Newsholme, et al., 2003a, 2003b; Rutten, Engelen, Schols, & Deutz, 2005). It
has been used in both medical and athletic settings to try to enhance fluid absorption (Hoffman et
al., 2010; Hoffman et al., 2011; Hoffman et al., 2012; Mertes et al, 2000; Novak, Heyland,
Avenell, Drover, & Su 2002). During prolonged starvation, sepsis, and long duration physical
activity, glutamine concentrations may become deficient (Castell, Poortmans, & Newsholme,
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1996; Hankard, Haymond, & Darmaun, 1997; Parry-Billings, Leighton, Dimitriadis,
Vasconcelos, & Newsholme, 1989; Santos, Caperuto, & Costa Rosa, 2007;). The decrease in
plasma glutamine following long duration exercise may be caused by several factors, including
an increase in glutamine extraction by the liver to increase gluconeogenesis or for urea
formation, and increased rate of utilization by cells, in particular the kidneys and immune
system, or a decreased rate of glutamine being released from the skeletal muscles (Newsholme,
1994).
When glutamine is supplemented, there is a problem with absorption due to the low pH in
the gut and the low solubility of glutamine (Fürst, 1998; Fürst, Pogan, & Stehl, 1997; Stehle et
al, 1989). The addition of alanine to the glutamine molecule increases the stability of glutamine,
especially at low pH as seen in the gut (Fürst, 2001). Additionally, alanine is considered the
most gluconeogenic amino acid (Klein, Nyhan, & Kern, 2009) and has been identified as a major
gluconeogenic precursor in prolonged exercise (Ahlborg, Felig, Hagenfeldt, Hendler, & Wahren,
1974). Hoffman and colleagues (2010) examined the efficacy of the alanine-glutamine dipeptide
in participants that were dehydrated to -2.5% of their body weight and then rehydrated to -1.5%
with the dipeptide. Participants were also required to cycle to exhaustion at 75% of VO2max.
The investigators reported significantly greater times to exhaustion in participants that were
provided the dipeptide compared to a no fluid trial (Hoffman et al., 2010). Interestingly, time to
exhaustion was not significantly different between the no fluid trial and water only trial. In
research examining the effect of ingesting three different rehydration fluids (an artificiallyflavored placebo, a commercial sports drink, and a rehydration electrolyte drink with glutamine)
on endurance performance, Snell and colleagues (2010) saw an improvement in run to
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exhaustion time with the rehydration electrolyte drink following a 60 min run at 70 to 75% of
VO2max. The runners ran the 60 min run followed by 60 min of rest, performed the run to
exhaustion, rested 60 min during which time fluid was ingested to replace the amount of fluid
lost during the 60 min run and then performed one final run to exhaustion.
The efficacy of alanine-glutamine ingestion and athletic performance has also been
demonstrated during competitive games. Hoffman and colleagues (2012) studies the effect of
the dipeptide on female basketball players. Their results were consistent with the other studies
examining the benefits of alanine-glutamine dipeptide in preventing performance decrements
during a dehydration stress. Others have shown significant improvements in distance covered
when consuming glutamine combined with carbohydrates and water, versus carbohydrates and
water alone in soccer players during simulated soccer activities (Favano et al., 2008).
Considering that the alanine-glutamine dipeptide is suggested to enhance water and
electrolyte absorption, studies to date have not examined the efficacy of ingesting the
combination of the dipeptide with a sports drink containing electrolytes. Thus, the purpose of
this study was to evaluate the efficacy of the L-Alanyl-L-Glutamine dipeptide mixed in a
commercial sport drink on changes in plasma concentrations of glutamine, sodium, and
potassium compared to the sport drink alone during prolonged endurance exercise in male
endurance-trained runners. An additional purpose of the study was to examine the physiological
effects of the dipeptide on oxygen consumption, heart rate, respiratory quotient and muscle
activation patterns and neuromuscular fatigue during prolonged endurance exercise in male
endurance-trained runners.

4

Hypotheses
1. It was hypothesized that adding the dipeptide L-Alanyl-L-Glutamine to a sport drink will
significantly increase absorption as measured by plasma glucose, electrolytes, and glutamine
during prolonged running by endurance-trained males.
2. It was hypothesized that adding the dipeptide L-Alanyl-L-Glutamine to a sport drink will
significantly reduce the cardiovascular strain as measured by oxygen consumption, heart rate,
and respiratory quotient during prolonged running by endurance-trained males.
3. It was hypothesized that adding the dipeptide L-Alanyl-L-Glutamine to a sport drink will
significantly improve muscle activation patterns and neuromuscular fatigue as measured by
electromyography root mean square signals from the vastus lateralis and rectus femoris muscles
during prolonged running by endurance-trained males.

Assumptions (Theoretical)
1. Subjects accurately answered the medical history and activity questionnaire.
2. All subjects gave maximal effort when performing the VO2peak test and isometric leg
extension test.
3. Participants maintained their current training routine throughout the duration of the study.
4. Participants consumed a similar diet prior to each experimental testing session.
5. Participants were well-rested prior to each experimental testing session.
6. Participants were unable to identify which drink was consumed during experimental trials T2
through T4, and there was no influence on effort during the trial.
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7. The weight loss during T1 is approximately the sweat rate for that participant, with no
consideration to the loss of the metabolic fuel used during the run.
8. The absorption and effect of the dipeptide L-Alanyl-L-Glutamine is the same across
individuals.

Assumptions (Statistical)
1. The population from which the samples are drawn is normally distributed.
2. The sample was randomly selected and the treatment order was randomly assigned.
3. The data met the assumption of sphericity. This requires that the repeated measures data
demonstrate both homogeneity of variance and homogeneity of covariance.

Limitations
1. Because the participants were male only, this could impact generalizability. Furthermore, the
participants were endurance-trained males, which could further impact generalizability.
2. The main recruiting mechanism was in-class announcements through the College of Education
courses, which made subject selection not truly random, which could affect internal validity.
3. The sample was made up of volunteers, therefore, not meeting the underlying assumptions of
random selection.

6

CHAPTER II
Literature Review
Glutamine
Glutamine is a naturally occurring nonessential amino acid. In humans, glutamine is the
most abundant amino acid in the body, found in all tissues in the body including the plasma, with
the largest storage area in skeletal muscle (Felig, 1975). The resting level of glutamine in the
plasma has been reported to range between 550 and 750 µmol∙L-1, while glutamine
concentrations within skeletal muscle is approximately 20 mmol∙kg-1 wet weight (Jonnalagadda,
2007). Glutamine is involved in many physiologic functions including cellular proliferation,
acid-base balance, transport of ammonia between tissues, and antioxidant synthesis (Curi et al.,
2005; Newsholme, et al., 2003b; Rutten et al., 2005). Glutamine supplementation stimulates an
increase in protein synthesis in the muscle (Jepson, Bates, Broadbent, Pell, & Millward, 1988;
MacLennan, Brown, & Rennie, 1987), improves glycogen resynthesis (Bowtell et al., 1999;
Varnier, Leese, Thompson, & Rennie, 1995), and can lead to an improvement in performance
(Favano, et al., 2008; Hoffman, et al., 2010). Glutamine has also been shown to enhance fluid
and electrolyte absorption in both animal and human models (Lima et al., 2002; Silva, et al.,
1998; van Loon, et al., 1996).
During times of severe stress, especially in catabolic states, glutamine requirements are
dramatically increased (Ziegler, Smith, Byrne, & Wilmore, 1993). These stresses can be in the
form of prolonged starvation, sepsis, and long duration physical activity (Castell et al., 1996;
Hankard et al., 1997; Parry-Billings et al., 1989; Santos et al., 2007). When endogenous stores
are unable to meet requirements, skeletal muscle becomes the source of glutamine through
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muscle catabolism (Ziegler et al, 1993). Low plasma glutamine has been correlated to an
unfavorable outcome in critically ill patients (Berg, Rooyackers, Norberg, & Wernerman, 2005)
and intravenous supplementation of glutamine has been shown to decrease mortality and
morbidity (Novak et al., 2002). Glutamine supplementation in post-operative patients has been
shown to decrease morbidity and lead to a shorter hospital stay (Mertes et al, 2000). In an
animal model, Silva and colleagues (1998) demonstrated in rabbits that glutamine added to an
oral rehydration solution can increase the rate of fluid absorption greater than water alone. In a
rat model, Lima et al. (2002) showed that the addition of glutamine to an oral nutritional
rehydration solution enhances electrolyte and water absorption. Van Loon and colleagues (1996)
demonstrated in a human model, increased water absorption via glutamine supplementation in an
oral hydration solution versus the oral hydration solution alone.
Ingestion of supplemental glutamine has been shown to enhance plasma glutamine
concentration, with peak values attained approximately 30 to 50 min following supplementation
(Castell and Newsholme, 1997; Harris, Hoffman, Allsopp, & Routledge, 2012; Klassen,
Mazariegos, Solomons, & Fürst, 2000). Harris, Hoffman, Allsopp, and Routledge (2012)
demonstrated with eight healthy males that supplementing with 60 mg∙kg-1 body weight of
glutamine, there was a 179 ± 61 µmol∙L-1 increase in plasma glutamine level within 30 min of
ingestion. All eight participants had an increase in plasma glutamine concentration. However, a
number of studies have reported that the stability of glutamine in an acidic environment is not
consistent (Fürst et al., 1997; Fürst, 1998; Stehle et al, 1989). Additionally, glutamine is
unstable during heat sterilization and prolonged storage for later use (Fürst et al, 1997). Due to
these factors there were a number of strict guidelines for the preparation of fluids containing
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glutamine, including fresh preparation under aseptic conditions, sterilization by membrane
filtration, no greater than 2.5% glutamine concentration, and stored at 4°C (Fürst et al, 1997;
Fürst 1998).

Alanine
To overcome the problems with acidity and water solubility, the addition of alanine to
form a dipeptide (such as L-alanyl-L-glutamine) increases the stability of glutamine, especially
at low pH (Fürst, 2001). This has important implications for oral ingestion of the dipeptide. A
number of studies have shown that when alanine is combined with glutamine to form the
dipeptide L-alanyl-L-glutamine there is an increase in absorption of glutamine into the plasma
(Arii, Kai, & Kokuda 1999; Fürst 2001; Harris, et al, 2012). In a study with humans, Harris and
colleagues (2012) examined eight male participants who supplemented with 89 mg∙kg-1 of Lalanyl-L-glutamine and reported a 284 ± 84 µmol∙L-1 increase in plasma glutamine levels. The
increase in plasma glutamine following L-alanyl-L-glutamine supplementation was significantly
greater than the increase in plasma glutamine following glutamine supplementation alone.
Alanine is considered the most gluconeogenic amino acid (Klein, Nyhan, & Kern, 2009)
and has been identified as a major gluconeogenic precursor in prolonged exercise (Ahlborg et al.,
1974). Carraro, Naldini, Weber, and Wolfe (1994) examined the alanine flux during exercise in
five healthy males utilizing labeled alanine. Participants were examined on two occasions; once
while walking on a treadmill at 45% of their VO2max for 2 hr and a second time that required no
exercise and served as a control. Results showed a nearly 50% increase of plasma alanine during
the exercise trial compared to the rest trial.
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Glutamine and Exercise
The plasma concentration of glutamine during exercise is dependent on the duration and
intensity of the activity (Gleeson, 2008). During high intensity exercise lasting less than 1 hr,
studies have shown both an increase (Babij, Matthews, & Rennie, 1983; Sewell, Gleeson, &
Blannin, 1994) and no change (Robson, Blannin, Walsh, Castell, & Gleeson, 1999) in plasma
glutamine concentration. Babij et al. (1983) speculated that the increase in plasma glutamine
concentrations during high intensity exercise may be the result of the production of ammonia,
which combined with glutamate forms glutamine. The research examining plasma glutamine
concentration in prolonged exercise is consistent in showing a decrease in activities lasting
longer than 2 hr. Mourtzakis, Saltin, Graham, and Pilegaard, (2006) had six men cycle at 44% of
VO2max to exhaustion and saw an initial rise in plasma glutamine concentrations during the first
2 hr. After 3 hr of exercise glutamine concentrations returned to baseline levels and continued to
decrease at the point of exhaustion (3 hr 23 min ± 11 min) with a continued decrease during the 3
hr of recovery. Parry-Billings and colleagues (1992) demonstrated that following a marathon,
there was a significant decrease in plasma glutamine concentrations in 24 endurance trained
runners.

Hydration and Exercise
During prolonged exercise, even in a thermoneutral environment, there is a need for fluid
and electrolyte ingestion to decrease the effects of dehydration (Coyle, 2004). During endurance
events dehydration can impact endurance performance with studies showing that weight loss as
little as 2 to 3% of body weight can impair performance (Coyle, 2004; Goulet, 2013; Montain,
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2008). Dehydration plays a role in the cardiovascular strain during endurance activities, with
research showing that for every 1% decrease in body weight, there is an increase in heart rate of
5 to 8 beats∙min-1 (Cheuvront, 2003; Cheuvront and Haymes, 2001a, 2001b; Coyle and Montain,
1992a,1992b; Sawka et al., 2007). The loss of fluid causes a decrease in blood volume which
decreases stroke volume, which can decrease oxygen delivery to the working muscles (Coyle,
2004). In addition to the cardiovascular impact from fluid loss, electrolytes are lost from the
plasma, with sodium being the most abundant electrolyte lost in sweat (Maughan, 2000). The
sodium and potassium balance is another factor that can lead to fatigue in endurance athletes
(Cairns & Lindinger, 2008). The addition of an L-alanyl-L-glutamine supplement could
potentially increase fluid and electrolyte absorption, possibly enhancing performance.

Electrolytes during Exercise
Plasma electrolytes play an important role in cellular homeostasis (Bangsbo, Gunnarsson,
Wendell, Nybo, & Thomssan, 2009; Nordborg et al., 2008;). In the resting muscle cell,
extracellular sodium levels are higher than intracellular levels with the opposite being true for
potassium, intracellular levels are higher than extracellular levels (McArdle, Katch, & Katch,
2010). During exercise, venous plasma potassium levels increase with the intensity of exercise
(Medbo & Sejersted, 1990). The increased extracellular potassium concentration during exercise
can be explained by the increased electrical activity in the exercising muscle (Medbo &
Sejersted, 1990). This increased extracellular potassium may cause fatigue during exercise due
to impaired membrane excitability (Fitts, 1994).
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Extracellular sodium concentration may increase at the onset of endurance exercise (due
to hemoconcentration) and then remain constant during moderate duration exercise depending on
exercise intensity and fluid loss (Cairns & Lindinger, 2008; Fortney, Vroman, Beckett, Permutt,
& LaFrance, 1988). During prolonged endurance exercise, especially in a warm environment
with heavy sweat loss, plasma sodium concentration may eventually decrease (Coyle, 2004).
There appears to be a large safety margin when looking at the peak force and extracellular
sodium relationship (Cairns & Lindinger, 2008). A decrease in extracellular sodium
concentration of 50% results in a 10 to 15% decrease in peak tetanic force production (Cairns,
Buller, Loiselle, & Renaud 2003; Jones & Bigland-Ritchie, 1986; Overgaard, Nielsen, &
Clausen, 1997). A decrease in extracellular sodium alone is not likely to cause muscular fatigue,
although there is a possibility of an impact on the action potential, with smaller action potentials
seen, skipping or propagation failure, which would leave some fibers unexcitable (Bezanilla,
Caputo, Gonzalez-Serratos, & Venosa, 1972; Cairns et al., 2003; Duty & Allen, 1994). The
interaction of sodium and potassium on muscular fatigue appear to be additive (Cairns, 2005;
Cairns & Dulhunty, 1995). Moderately raised extracellular potassium with lowered sodium can
reduce peak tetanic force by as much as 67% in mouse muscle, demonstrating the synergistic
impairment on force production (Cairns & Lindinger, 2008).

Fluid Ingestion and Plasma Electrolytes
Several investigations have been conducted examining fluid ingestion, plasma
electrolytes, and exercise performance in events lasting approximately 1hr. Fallowfield,
Williams, Booth, Choo, and Growns (1996) examined whether water ingestion during a treadmill

12

run to exhaustion at 70% of VO2max (in a thermoneutral environment, 20°C) can limit
dehydration and improve endurance capacity when compared to no fluid ingestion. Plasma
electrolyte responses were similar between the trials with plasma potassium increasing a
significant 21% (p < 0.01) (4.00 ± 0.18 to 4.83 ± 0.15 mM) during the no fluid replacement trial
and a significant 23% (p < 0.01) (4.08 ± 0.10 to 5.00 ± 0.32 mM) during the fluid replacement
trial. There was no difference between the trials. Plasma sodium concentrations were not
different from pre to post for the individual trials or between the trials. During the no fluid trial
the plasma sodium went from 140 ± 0.7 to 142 ± 0.8 mM and during the fluid replacement trial
went from 139 ± 0.7 to 142 ± 1.3 mM. There was a significant difference (p < 0.01) in the mean
run time (no fluid trial = 77.7 ± 7.7 min fluid replacement trial = 103.0 ± 12.4 min).
In research examining endurance capacity, Snell and colleagues had runners complete a
60 min run at 70 to 75% of VO2max followed by 60 min of rest, perform a run to exhaustion
lasting 7 to 10 min, rest for 60 more min during which time fluid was ingested to replace the
amount of fluid lost during the 60 min run and then perform one final run to exhaustion. The
rehydration drinks were an artificially-flavored placebo, a commercial sports drink, and a
rehydration electrolyte drink with glutamine. The results revealed that the run to exhaustion
following ingestion of the rehydration electrolyte solution was significantly better than the other
two drinks, nearing the baseline performance in a euhydrated state. Unfortunately, plasma
electrolytes, glucose, or glutamine were not measured (or reported) in this investigation.
In a study designed to examine cycling performance at 85% of VO2max while ingesting
three different fluids (non-electrolyte placebo, carbohydrate drink with electrolytes, and placebo
with electrolytes), Powers and colleagues (1990) found that there was no difference in plasma
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sodium or potassium between the trials. Although no specific data was presented, interpreting
the data from the figures, plasma sodium increased from approximately 142 mEq∙L-1 at rest to
approximately 145 mEq∙L-1 throughout the exercise bout. Plasma potassium increased across all
trials from an initial concentration of approximately 3.9 mEq∙L-1 at rest to approximately 5.0
mEq∙L-1. Robinson et al. (1995) conducted an investigation to examine whether an attempt to
replace a large amount of fluid loss during intense exercise improves performance in moderate
temperatures. Eight cyclists rode as far as possible in 1 hr either with no fluid or an artificially
sweetened water. There were no differences in the increases in plasma potassium concentrations
between trials. During the first 5 min of exercise the increases in plasma sodium concentrations
were the same. From the 5 min mark on, there was a significant difference (p < 0.005) in plasma
sodium concentrations between trials, with the fluid replacement trial remaining lower than the
no fluid trial at all time points. Plasma osmolality followed a similar pattern as sodium. There
were similar initial increases in plasma osmolality during the first 5 min. From the 20 min point
on, there was a trend toward a difference (p = 0.054) between trials, with the fluid replacement
trial lower than the no fluid trial.
McConell, Stephens, and Canny (1999) investigated whether fluid ingestion volume had
an impact on heart rate, plasma osmolality, plasma electrolytes, and performance during an
intense endurance exercise in a moderate environment (21°C). Eight cyclists/triathletes
completed three trials in which they rode for 45 min at 80% of VO2max then completed a 15 min
performance trial during which they were instructed to complete as much work as possible. The
three trials consisted of no fluid, a trial where they consumed enough fluid (water) to replace
50% of the fluid lost, and a trial in which they consumed enough fluid (water) to replace 100%
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of the fluid lost. There were no differences in the work performed during the three trials.
Plasma sodium was not different across the trials during the first 30 min, but tended (p = 0.07) to
be higher in the no fluid trial late in the exercise. Plasma potassium was not different across the
trials, increasing in a similar fashion.
It appears that during endurance exercise lasting approximately 1 hr, plasma potassium
concentrations increase regardless of fluid ingestion. The pattern of plasma sodium
concentration changes appear to differ in that regardless of fluid ingestion, there is an initial
increase in extracellular sodium concentration. Following the initial rise in sodium
concentration, during fluid ingestion trials sodium appears to remain constant. With no fluid
ingestion the data is equivocal, some investigations reporting an increase in sodium
concentration while others report a constant sodium concentration.

Methods to Enhance Hydration
There are a number of methods that have been proposed to enhance rehydration during
exercise, including ingestion of glycerol, betaine, and alanine-glutamine. A number of
investigations have been conducted with glycerol to examine fluid retention and
thermoregulation. The data appear to be equivocal with several studies showing an improvement
in performance with glycerol ingestion (Dini, Corbianco, Rossi, & Lucacchini, 2007; Hitchins et
al., 1999; Montner, et al., 1996; Ohkuwa, Miyamura, Andou, & Utsuno, 1988), while others
reporting no improvement in performance (Inder, Swanney, Donald, Prickett, & Hellemans,
1998; Magal et al., 2003; Marino, Kay, & Cannon, 2003; Murray, Eddy, Paul, Seifert, & Halaby,
1991). Dini and colleagues (2007) examined glycerol ingestion in competitive rowers and
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found an approximate 37 m improvement in performance. In cycling trials, Montner et al.
(1996) and Hitchins et al. (1999) showed improved performance with glycerol ingestion,
although in the Hitchins’ study, the improvement in performance (higher power output) was
attributed to a lower perception of effort. In a running trial, Ohkuwa and colleagues (1988)
found significant improvements in performance following glycerol ingestion. In contrast, Inder
et al. (1998) showed no improvement in performance when glycerol was provided to triathletes.
In a study examining glycerol ingestion during tennis performance, Magal et al. (2003) found an
improvement in hydration status and expanded plasma volume from the glycerol ingestion
compared to water only but no improvement in tennis-related performance. In addition, Murray
and colleagues (1991) found no significant improvement in cardiovascular or thermoregulatory
responses during 90 min of cycling at 50% of VO2max even though glycerol ingestion attenuated
the normal decrease in plasma volume when compared to a water placebo and carbohydrate
electrolyte drink.
Betaine is an organic osmolyte and is thought to protect cells under stress including
hydration stress. Armstrong and colleagues (2008) showed a non-significant 16% improvement
in a run to exhaustion at 84% of VO2max following betaine supplementation. Millard-Stafford
et al. (2005) examined eight trained cyclists who cycled for 120 min in a warm environment
which was followed by a 15 min time trial. In addition, participants were also required to
perform an isometric knee extensor test. Participants hydrated with either a 6% carbohydrate
solution, 7% carbohydrate solution with betaine, or a placebo. There were no time trial
performance differences between the treatments, but during the betaine trial, participants were
reported to have significantly higher isometric knee extensor strength.
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There have been few studies examining endurance performance with alanine-glutamine
supplementation. During a cycling trial to exhaustion, Hoffman and colleagues (2010) examined
10 physically active males cycling at 75% of VO2max to exhaustion following a dehydration
protocol. Participants were dehydrated to -2.5% of body weight at the beginning of the protocol
and then rehydrated to -1.5% of body weight prior to the cycling trial. Exercise performance
(time to exhaustion) was significantly lower during the no hydration trial when compared with
the rehydration trials when provided the alanine-glutamine dipeptide, but not different between
the water and dipeptide trials. The authors concluded that supplementing with alanine-glutamine
provided a significant increase in time to exhaustion (during a mild hydration stress) and the
effect was likely due to enhanced fluid and electrolyte uptake. In research where glutamine
levels were not measured, Favano and colleagues (2008) demonstrated in nine male soccer
athletes a significant increase in distance covered (22% increase) in treadmill activity simulating
soccer activities following ingestion of a carbohydrate-glutamine peptide drink. The soccer
athletes had lower Borg scale feelings of perceived exertion during the first two batteries (of
three) of the trials. The trials were comprised of 3 x 25 min batteries of various exercises
simulating a soccer match.

Neuromuscular Fatigue and Economy
Neuromuscular fatigue is defined as the inability to produce or maintain maximal
voluntary force (Kent-Braun, 2009). Neuromuscular fatigue is a complex phenomenon in which
there is an interruption of the muscle activation signal somewhere between the brain and muscle.
The interruption could be central in nature, with a disruption in recruitment or rate coding of the
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signal. It could be in the peripheral nervous system, in which conduction velocity, membrane
excitability, or the neuromuscular junction is affected. Or the interruption could be in the muscle
where the action potential is disrupted at some point affecting the contractile function of the
muscle. The disruption could be in the excitation-contraction coupling, caused by a change in
the calcium concentration in the muscle, or caused by a change in the cross-bridge function of
the muscle (Kent-Braun, 2009).
As described by Cadore et al. (2011b), neuromuscular economy can be defined as the
lower muscle activation represented by a lower EMG signal amplitude that is necessary to move
the same absolute load. The load could be weight on a leg extension machine, resistance on an
isokinetic machine, the resistance (in wattage) on a cycle ergometer, or the speed on a treadmill.
The person with the lower signal amplitude would be considered more economical at the same
load (resistance).
Neuromuscular economy can be measured utilizing both a strength measure (e.g., an
isokinetic machine or leg extension machine) and an endurance measure (e.g., running on a
treadmill or cycling on a cycle ergometer). To measure neuromuscular economy using an
endurance measure, participants would cycle at the same wattage or run at the same speed with
EMG being measured. The more economical cyclist would have a lower EMG signal. Cadore
and colleagues (2011b) explained that the more economical cyclist may be recruiting fewer
motor units to perform the set workload, resulting in a lower EMG signal. Also, the more
economical cyclist would rely more on type I motor units, which have a lower activation
threshold, leading to the lower EMG signal (Cadore et al., 2011a). Heise, Morgan, Hough, and
Craib (1996) explained that more economical runners may rely more on the use of a bi-articular
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muscle (rectus femoris) to contribute to the dual function of hip flexion and knee extension in
contrast to using mono-articular knee extension. The decrease in electrical activity in the
quadriceps muscle during aerobic activity indicates that fewer motor units were recruited for the
same load, suggesting that economy of movement can occur (Cardore et al., 2011a).
Hanon, Thépaut-Mathieu, and Vandewalle (2005) examined the onset of fatigue in the
major muscles involved in running. The authors had nine well-trained male runners (VO2max =
76.1 ± 2.9 ml∙kg-1∙min-1) run on a motorized treadmill utilizing a discontinuous protocol of 4 min
stages of increasing speed to exhaustion. The runners were outfitted with surface
electromyography to record the EMG signals for the vastus lateralis, rectus femoris, biceps
femoris, tibialis anterior, gastrocnemius, and gluteus maximus. The major finding from this
study was that during running, the hip-mobilizing muscles (rectus femoris and biceps femoris)
become fatigued earlier than the other lower limb muscles analyzed in this study.
In a study designed to evaluate the changes in leg-spring behavior and the associated
modifications in the lower limb muscular activity utilizing EMG, Rabita and colleagues (2013)
had 12 trained runners (VO2max = 60 ± 6.4 ml∙kg-1∙min-1) run at their VO2max velocity to
exhaustion. The authors recorded the EMG signals for eight leg muscles of the right leg,
including the soleus, gastrocnemius medialis, gastrocnemius lateralis, tibialis anterior, vastus
medialis, vastus lateralis, rectus femoris, and biceps femoris. The results indicate that the
plantarflexors were more affected by the run than the knee extensors, and the biarticular
muscles, rectus femoris and biceps femoris seem to play an important role in order to maintain the
preset velocity during the latter part of an exhaustive, high velocity run.
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Zuniga and Malek (2013) examined the individual patterns of response of the three
superficial thigh muscles (vastus lateralis, rectus femoris, and vastus medialis) utilizing EMG in
a treadmill running test of increasing speed. The authors had nine physically active men run one
min continuous stages on a motorized treadmill until voluntary exhaustion. The authors
averaged the last three complete EMG bursts during the stance phase during the last 10 s of each
stage to get their EMG amplitude values. The authors found that the patterns of response of the
EMG signal amplitude across running velocities were consistent for all three quadriceps muscles.
They further concluded that the normalized EMG amplitude did increase as running velocity
increased, but this was independent of muscle group.
No published studies are known that examined the effect of adding the alanine-glutamine
dipeptide to a low-calorie sports drink during an endurance event in euhydrated participants.
This research will examine serum electrolyte concentrations, blood glucose levels, EMG
economy, and running performance in euhydrated endurance-trained males. The outcomes of
this study will contribute to the scholarly knowledge in the exercise science community. In
particular, does a dipeptide enhance absorption of glucose and electrolytes during a 1 hr run at
75% of VO2max and if so, does that improve running performance and muscle recruitment
activity during a subsequent run to exhaustion at 90% of VO2peak in endurance-trained male
runners.
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CHAPTER III
Methods
Research Design
The research design of this study was a double-blind, randomized, placebo-controlled,
cross-over study. Participants were asked to report to the Human Performance Lab (HPL) on six
separate occasions. The first two visits were preliminary visits (PV1 and PV2) followed by four
experimental trial visits (T1 – T4). During PV1, participants completed the Confidential
Medical and Activity questionnaire, Physical Activity Readiness Questionnaire (PAR-Q), and
informed consent form and any questions were addressed. Prior to PV2, participants completed
a 24 hr food log, which was considered their pre-testing diet, and participants were asked to
replicate this diet prior to all experimental trials.
During PV2 participants were weighed and asked to provide a urine sample to measure
baseline euhydration levels. Participants were provided with a specimen cup to use for urine
collection. Each sample was analyzed for osmolality (Uosm) and specific gravity (Usg). Uosm was
measured by freezing point depression (Model 3320 MicroSample Osmometer, Advanced
Instruments, Inc., Norwood, MA) and Usg by refractometry (Human Urine Refractometer,
MISCO Refractometer, Cleveland, OH). These measures were used to document euhydration on
all testing days. Participants were considered euhydrated if Usg ≤ 1.020. During PV2
participants also performed a lactate threshold (LT) and VO2peak test to determine the treadmill
speed for T1 – T4.
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Figure 1. Study Protocol
Data collection for T1 – T4 occurred on four separate occasions separated by a minimum
of 7 days with a mean of 8.4 ± 3.3 days (Figure 1). Prior to each experimental trial, participants
were weighed in running shorts. During each experimental trial, participants completed a 60 min
run at 75% of their previously measured VO2peak. Following the 60 min run, participants were
towel dried, put on dry running shorts, and were weighed to measure sweat loss. The
participants then completed a run to exhaustion with treadmill speed adjusted to produce 90% of
their VO2peak. T1 was performed without any rehydration (NHY). The fluid loss during this
session was used to determine the participant’s sweat rate (L∙hr-1). To continue in the study, the
participant’s sweat rate needed to be or exceed 1.3 L∙hr-1. All participants met or exceeded 1.3
L∙hr-1 of sweat loss, with a mean sweat loss of 1.68 ± 0.22 L∙hr-1. During T2, T3, and T4,
participants were provided 250 ml of sport drink every 15 min. The sport drink was a
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commercial product containing 21 calories, 4.9 g of carbohydrate, 113 mg of sodium, and 32 mg
of potassium per 250 ml (Gatorade G2, PepsiCo, Purchase, NY). During one of these trials,
participants consumed only the sport drink (ET), while during the other trials participants
consumed the alanine-glutamine supplement (Sustamine™) mixed in the same flavor sport drink
at either a low (300 mg∙500 ml-1) or high dose (1 g∙500 ml-1) (LD and HD, respectively). Trials
T2, T3, and T4 were performed in a randomized order. A laboratory worker not involved in the
investigation mixed the drinks to ensure a double-blind protocol was maintained. Participants
performed a maximal effort isometric contraction of the knee extensor muscles prior to T1
through T4 utilizing an isokinetic machine (System 4 Pro, BIODEX Medical Systems, Inc.,
Shirley, NY). During the maximal effort isometric contraction, electromyography (EMG) root
mean square (RMS) amplitude values were recorded. During each experimental trial, the EMG
RMS signal was recorded for 2 min every 10 min and throughout the run to exhaustion portion
of the trials. The values obtained every 10 min and throughout the run to exhaustion were
calculated and presented as a percent of maximum EMG RMS signal.

Participants
Twelve male endurance-trained athletes (23.5 ± 3.7 yrs; 175.5 ± 5.4 cm; 70.7 ± 7.6 kg)
volunteered for the study. All participants were recruited via word of mouth or flyer
advertisement throughout the university and local running community. All participants were free
of any physical limitations as determined by the Confidential Medical and Activity questionnaire
and PAR-Q. University Institutional Review Board approved all experimental protocols and
signed informed consent was obtained from each participant.
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VO2max and Lactate Threshold Testing
During PV2, participants performed a LT and VO2peak test. The LT testing protocol
consisted of six to eight discontinuous 5 min stages of increasing speed beginning at
approximately 40 to 50 m∙min-1 below estimated 10K racing speed. Expired gases were
analyzed with a metabolic cart (TrueOne, ParvoMedics, Sandy, UT) for oxygen consumption
and carbon dioxide production. Prior to the test, the participants estimated their 10 km race pace
and this time was converted to a running pace in m∙min-1. During the run, participants reached
their estimated 10 km running pace in the fourth or fifth stage. Running velocity was increased
by 10 m∙min-1 each stage. At the completion of each stage, participants straddled the treadmill
belt and a finger prick (Tenderlett Finger Incision Device, ITC, Edison, NJ) was utilized to
collect 50 µL of blood to test for blood lactate via automated analysis (Analox GM7 Enzymatic
Metabolite Analyzer, Analox Instruments USA, Lunenburg, MA). Blood lactate levels were
plotted against running speed with LT being defined as a minimum increase of 1.0 mmol∙L-1
above baseline followed by another increase greater than 1.0 mmol∙L-1 (Coyle et al., 1983). The
treadmill speed was increased 10 m∙min-1 until a clear LT was established. Following the final
stage of the LT test, participants were allowed a 10 min rest period. Once the participant was
back on the treadmill, the treadmill speed was set at the estimated 10 km racing speed.
Treadmill speed was increased 10 m∙min-1 every min until the participant could no longer
continue. The highest VO2 measure averaged over one min was considered VO2peak. This
measure was used to determine running velocity for the 60 min run (75% of VO2peak) and the
run to exhaustion (90% of VO2peak).
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Electromyography Testing
EMG measures were recorded during T1 – T4 to measure muscle activity of the right
vastus lateralis and rectus femoris. Prior to all experimental trials, a maximum isometric leg
extensor measurement was made with an isokinetic machine (System 4 Pro, BIODEX Medical
Systems, Inc., Shirley, NY). Participants performed three trials of 6 sec in duration with the
highest value recorded as their maximum value. Lab personnel provided verbal encouragement
throughout each trial. Participants were provided a 3 min rest between trials. Participants were
seated and securely strapped into the isokinetic machine with a hip angle of 90° and lower leg
extended 110°. All participant positioning measurements were recorded and repeated for each
subsequent trial.
To measure the EMG activity, a bipolar (4.6 cm center-to-center) surface electrode
(Quinton Quick Prep Electrodes, Cardiology Shop, Boston, MA) arrangement was placed over
the right vastus lateralis (VL) and rectus femoris muscles (RF). Electrodes over the VL were
placed two-thirds of the distance between the anterior, superior iliac spine (ASIS) and the lateral
patella, and 5 cm lateral to this line with the participant in a standing position. Electrodes over
the RF muscle were positioned halfway between the inguinal fold and the patella, with the
participant’s hip and knee flexed 90°. The RF muscle was palpated to ensure placement over the
belly of the muscle. A ground electrode was placed over the ASIS. All electrode measurements
were recorded and repeated for each trial. To ensure proper signal conductance, skin around the
marked areas was shaved, rubbed with alcohol, and once the electrode was placed on the skin,
the center of the electrode was spun causing a final abrasion of the skin. A 2-channel wireless
EMG transmitter (BIONOMADIX Dual-channel Wireless EMG Transmitter, BIOPAC Systems,
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Inc., Santa Barbara, CA) was used to transmit the EMG information to the receiver/amplifier
(MP150 BIOPAC Systems, Inc., Santa Barbara, CA). The transmitter was strapped to the thigh
approximately 3 cm above the top electrode. The electrodes and transmitter wires were wrapped
with cohesive bandage (Fisherbrand Cohesive Wrap Bandage, Thermo Fisher Scientific, Inc.,
Waltham, MA) to prevent wire slap and electrode movement.
During the experimental trials, EMG signals were recorded for the final 2 min of each 10
min period during the 60 min run and continuously during the run to exhaustion portion of the
trial. All EMG signals were expressed as RMS amplitude values (µVrms) by software
(AcqKnowledge v4.2, BIOPAC Systems, Inc., Santa Barbara, CA). The RMS values were
reported as the percentage of maximal leg extension value for that day.
The EMG RMS value from each maximal isometric contraction was analyzed using
methods described by Cadore, et al. (2010). The middle four seconds of the 6-second signal were
visually scanned for the maximum signal. The one second surrounding this peak was averaged
and used as the maximum RMS signal for that day. During the 1 hr run, the average RMS value
of the middle one minute of each two minute recording was computed and then compared to the
maximum RMS value determined from the maximal leg extension trials.

Blood Measurements
During each experimental trial, baseline (BL) blood samples were obtained with
additional blood samples drawn following 30, 45, and 60 min during the 60 min run. All blood
samples were obtained using a 20-gauge Teflon cannula placed in a superficial forearm vein
using a 3-way stopcock with a male luer lock adapter. Cannula placement and blood draws were
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performed by personnel trained in phlebotomy. BL blood samples were drawn following a 15
min equilibration period (participant lying supine) prior to exercise. Every effort was made to
test subjects on the same day of the week and same time each day during the experimental trials
to eliminate any diurnal variation in performance.
Blood samples were drawn into sodium heparinized treated tubes. Blood samples were
analyzed in triplicate for hematocrit and hemoglobin via microcapillary technique. The
remaining whole blood was centrifuged for 10 min at 3000 g at 4ºC. Resulting plasma and
serum was aliquoted and immediately analyzed for glucose, lactate, sodium, potassium, and
osmolality. All plasma measures were performed in duplicate. The remaining plasma was
stored at -80C for future analysis of glutamine. Plasma concentrations of glucose and lactate
were measured in duplicate via automated analyzer (Analox GM7 Enzymatic Metabolite
Analyzer, Analox Instruments USA, Lunenburg, MA). Plasma glutamine concentrations were
determined via assay (Glutamine Assay Kit, Abnova Corporation, Taiwan). Plasma sodium and
potassium concentrations were determined via ion-selective electrodes (EasyLyte, Medica
Corporation, Bedford, MA). Plasma osmolality was measured by freezing point depressions
(Model 3320; Micro-Sample Osmometer, Advanced Instruments, Inc., Norwood, MA). Samples
that were frozen were thawed only once.

Statistical Analysis
All data are reported as mean ± standard deviation. All data were analyzed utilizing a
two-way (time x treatment) repeated measures analysis of variance (ANOVA). When the
analysis produced a significant interaction, follow-up analysis was via one-way ANOVA
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comparison among treatments and if significant, then a LSD test was used for post hoc
comparison. When a significant main effect for time was found, then follow-up repeated
measures ANOVA with LSD post hoc was used to examine each treatment for time effect. An
alpha level of p < 0.05 was used to determine statistical significance. All statistical analyses
were conducted utilizing the Statistical Package for Social Science (SPSS) software for Windows
version 20 (IBM Corp., 2012).
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CHAPTER IV
Results
Running Performance
The temperature and relative humidity for all trials was consistent (22.92 ± 0.28 °C and
44.19 ± 1.33%). All participants completed each trial and each participant consumed all 250ml
of fluid every 15 min (total = 1L) during the fluid replacement trials. A significant difference
[F(3,33) = 50.09, p < 0.001] in body mass loss occurred during the 1 hr run (Figure 2).

Figure 2. Body mass loss during 1 hr run.

Post-hoc analysis showed a significant difference between the NHY trial (1.68 ± 0.23 kg;
2.4 ± 0.36% of body weight (BW)) and ET (0.63 ± 0.26 kg; 0.9 ± 0.35% BW, p < 0.001), LD
(0.74 ± 0.39 kg; 1.1 ± 0.55%, p < 0.001), and HD trials (0.68 ± 0.44 kg; 1.0 ± 0.62%, p < 0.001).
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A significant difference [F(3,33) = 3.22, p = 0.035] was observed in run-to-exhaustion
performance at 90% of VO2peak following a 1 hr run at 75% of VO2peak (Figure 3). Post hoc
analysis revealed a significant difference between the NHY trial (368.33 ± 197.92 sec) and the
LD trial (528.67 ± 196.76 sec, p = 0.025) and HD trials (562.17 ± 293.11 sec. p = 0.023).
Although a trend was seen between NHY and ET (499.00 ± 161.53 sec. p = 0.086) trial, no other
significant differences were observed.

Figure 3. Run to exhaustion performance.
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Metabolic Measurements
The mean VO2peak for the participants was 55.94 ± 5.92 ml∙kg-1∙min-1. The mean
percent of VO2peak utilized across the 1 hr run for all trials was 74.0 ± 3.1%. The mean percent
of VO2peak utilized during the RTE portion of all trials was 89.0 ± 5.8%. There was no
significant effects for time [F(3,30) = 2.84, p = 0.055], treatment [F(3,30) = 2.61, p = 0.070], or time
x treatment interaction [F(9,90) = 0.99, p = 0.457] for VO2 (ml∙kg-1∙min-1) measured every 15 min
during the 1 hr run (Figure 4).

Figure 4. VO2 during 1 hr run.
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Comparison of changes in RQ between trials can be observed in Figure 5. There was a
significant main effect for time for RQ across the 1 hr run [F(3,30) = 3.12, p = 0.041]. Analysis of
the time means (collapsed across treatments) revealed significant differences between the 15 min
and 60 min RQ (p = 0.014) and between the 45 min and 60 min RQ (p = 0.045). Follow-up
analysis of time differences for each treatment showed that during the LD trial the 15 min RQ
was significantly higher than the 60 min RQ (p = 0.049) and during the ET trial the 15 min RQ
was significantly higher than the 60 min RQ (p = 0.009). There was no significant effect for
treatment [F(3,30) = 2.02, p = 0.132] nor any time x treatment interaction for RQ [F(9,90) = 1.55, p
= 0.145].

Figure 5. Respiratory Quotient during 1 hr run.
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Comparisons of changes in heart rate between trials are depicted in Figure 6. There was
a significant main effect for time [F(1.44,14.39) = 18.34, p < 0.001], a significant main effect for
treatment [F(3,30) = 3.95, p =0.017], and a significant time x treatment interaction [F(3.16,31.58) =
3.00, p = 0.043]. Significant differences were noted between heart rate at 15 min, and the heart
rate at all other time points for all trials (30 min, p < 0.001; 45 min, p = 0.001; 60 min, p =
0.001). In addition, during the LD trial the heart rate at 60 min was significantly higher than at
30 min (p = 0.05). During the ET and HD trials, heart rates at 30, 45 and 60 min were
significantly lower than the heart rates seen during NHY (p < 0.05).

Figure 6. Heart rate during 1 hr run.
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Blood and Plasma Analysis
Changes in plasma glutamine are shown in Figure 7. A significant increase in plasma
glutamine concentration was observed between PRE and 45 min for both LD (p = 0.003) and HD
(p = 0.017). At 60 min, during the HD trial, the plasma concentration of glutamine remained
significantly higher than the PRE value (p = 0.05). In addition, significant differences were also
noted between 30 min and 45 min during LD (p = 0.013), and between the 30 and 60 min
measures during the HD trial (p = 0.006).

Figure 7. Plasma glutamine changes during 1 hr run.
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Changes in plasma sodium and potassium concentrations can be observed in Figures 8
and 9, respectively. There was a significant time x treatment interaction [F(9,72) = 3.98, p <
0.001], significant main effect for time [F(3,24) = 91.81, p < 0.001], and a significant main effect
for treatment [F(3,24) = 5.17, p = 0.007] for sodium across the 1 hr run. Plasma sodium
concentrations were significantly elevated from PRE to 30, 45, and 60 min for all trials (p <
0.05). During the NHY trial, plasma sodium concentrations increased significantly across each
time point (p < 0.05). Plasma sodium concentrations during NHY were significantly greater than
those seen during ET and HD at 45 min (p <0.05). In addition, plasma sodium concentrations at
60 min were significantly greater during NHY compared to all other trials, while plasma sodium
concentrations during LD were significantly greater than ET and HD (p < 0.05).

Figure 8. Plasma sodium during 1 hr run.
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A significant main effect for time was observed for plasma potassium concentrations
[F(1.84,14.74) = 98.68, p < 0.001]. PRE measures were significantly lower than all other time points
for all trials (Figure 8). During NHY, plasma potassium concentrations at 45 and 60 min were
significantly higher than seen at 30 min. During the ET trial the 60 min measure was
significantly higher than the 30 min measure, while plasma potassium concentrations at 60 min
during LD and HD were significantly higher than the 30 and 45 min measures.

Figure 9. Plasma potassium during 1 hr run.

Plasma glucose and plasma osmolality are shown in Figures 10 and 11, respectively. A
significant time x treatment interaction [F(3.21,28.87) =3.01, p = 0.044] and a significant main effect
for time was seen for glucose [F(1.66,14.92) = 26.27, p < 0.001]. Plasma glucose concentrations at
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30, 45, and 60 min for all trials were significantly higher than the PRE measure (p < 0.05).
Further, during the ET trial a significant decrease in plasma glucose concentrations was seen at
60 min. Plasma glucose concentrations were not significantly different between trials at any
time point.

Figure 10. Plasma glucose during 1 hr run.
A significant main effect for time [F(3,27) = 61.85, p < 0.001] and for treatment [F(3, 27) =
5.92, p = 0.003] was observed for plasma osmolality, but no time x treatment interaction [F(9,81) =
1.37, p = 0.214] were noted. When collapsed across trials, plasma osmolality was significantly
greater at 30, 45, and 60 min compared to the PRE measure. In addition, plasma osmolality was
significantly higher at 45 min compared to 30 min during NHY, ET, and HD, and a significantly
higher plasma osmolality was noted at 60 min compared to 30 min during the NHY trial.
Comparisons between treatments showed that plasma osmolality was significantly elevated at 45
min during NHY compared to ET and LD, while plasma osmolality at 60 min during the NHY
trial was significantly higher than all other trials.
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Figure 11. Plasma osmolality during 1 hr run.
Blood lactates are depicted in Figure 12. Blood lactate at 60 min was significantly higher
during NHY trial than ET and HD trials (p = 0.05). No other differences were noted between
trials at any time point.

Figure 12. Blood lactate during 1 hr run.
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EMG Analysis
Muscle activation of the vastus lateralis and rectus femoris during the 60 min run are depicted
in Figures 13 and 14, respectively. No significant differences in muscle activation were noted
between the trials in either muscle group.

Figure 13. Average EMG percentage utilized during 1 hr run for vastus lateralis.
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Figure 14. Average EMG percentage utilized during 1 hr run for rectus femoris.
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CHAPTER V
Discussion
Ingestion of the alanine-glutamine dipeptide resulted in significant elevations in plasma
glutamine that were similar to previous studies that reported glutamine appearance to occur
about 30 to 50 min following ingestion (Castell and Newsholme, 1997; Harris, et al., 2012;
Klassen et al., 2000). The decrease in glutamine concentration in the LD trial at 60 min suggests
that the lower dose (300mg∙500ml-1) may not be sufficient to sustain plasma glutamine
concentrations for the duration of an endurance event lasting longer than 45 min. However, the
performance results of the present study indicated that the ingestion of either a low (LD) or high
dose (HD) of the alanine-glutamine dipeptide mixed in a sport drink during a 1 hr, moderate
intensity run, was able to significantly improve time to exhaustion (43.5% and 52.6%,
respectively) compared to a no fluid ingestion (NHY) trial. Although ingestion of the dipeptide
resulted in a 12.7% greater time to exhaustion compared to the sport drink (ET) only, this was
not statistically different. These results support the previous investigation of Hoffman et al.
(2010), in which ingestion of both a low and high dose of the alanine-glutamine dipeptide also
resulted in significantly greater times to exhaustion compared to a no hydration trial. Similarly,
no differences were seen between the water only trial and the no hydration trial. In the present
study, the ET and NHY trial were not significantly different, however the 35.5% difference in
time to exhaustion between those two trials trended towards a difference (p = 0.086).
Interestingly, these results contrast from Fallowfield and colleagues (1996) who reported a
significant difference in time to exhaustion while running at 70% VO2max, between a water
ingestion trial and no fluid intake trial. The difference between these studies may be related to
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the training experience of the participants. The present study utilized endurance trained runners
while the Fallowfield and colleagues (1996) examined recreationally active participants. It is
possible that endurance trained runners are more accustomed to training with little hydration and
the differences between running without taking fluid and taking water or low carbohydrate
electrolyte beverage are not great enough to be detected (Coyle, 2004).
A possible explanation of the lack of any significant performance differences between the
sport drink with the dipeptide (both LD and HD trials) and ingestion of the sport drink without
the dipeptide (ET trial) may be related to the length or duration of the 1 hr run and its subsequent
effect on plasma electrolyte concentrations. Cairns and Lindinger (2008) suggested that plasma
electrolytes would have to change dramatically to affect muscle force production. Significantly
greater elevations in plasma sodium concentrations were seen at 45 and 60 min during NHY
compared to all fluid ingestion trials. Changes in plasma potassium concentrations did not differ
between trials. Although speculative, it is possible that a greater electrolyte absorption
occurring during the fluid ingestion trials stimulated a greater sodium uptake within the muscle,
maintaining muscle performance (Carlsen et al., 1996).
The electrolyte response seen during the trials was similar to previous studies
(Fallowfield et al., 1996; Robinson et al., 1995). Plasma sodium concentrations have been
reported to continuously elevate during a 1 hr bike ride at 85% of VO2max with no fluid
replacement (Robinson et al., 1995). When fluid is provided during this duration of exercise
sodium concentrations tend to increase and then plateau (Fallowfield et al., 1996; Robinson et
al., 1995), similar to the response seen in the present study. During the HD trial, the sodium
concentration at 60 min was significantly lower compared with the NHY and LD trials.
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Hoffman and colleagues (2010) speculated that the lower sodium concentration during the
glutamine trials may be indicative of a greater sodium uptake by the muscles when compared
with NHY trial. Plasma potassium concentrations increased approximately 17% from PRE to 60
min. This is within the range (10% - 23%) reported by others during a similar duration and
intensity of exercise (Fallowfield et al., 1996; Hoffman et al., 2010; Robinson et al., 1995).
Elevations in plasma potassium may be indicative of enhanced electrical activity in the muscles
(Medbo & Sejersted, 1990), enhanced mobilization of muscle glycogen (Cairns & Lindinger,
2008), or of muscle fatigue (Fink and Lüttgau, 1976; Nielsen et al., 2004). Considering the
duration of exercise performed at the participant’s sub-lactate threshold running pace, it is not
surprising fatigue during the moderate intensity run was not a factor. This is supported by the
EMG results noted in this study. No differences were seen in the percent activation of the vastus
lateralis (VL) or rectus femoris muscles (RF) between trials. Differences in the percent of
muscle activation between the VL and RF is similar to previous research (Hanon, ThépautMathieu, & Vandewalle, 2005). The VL is typically activated to a higher degree than the RF
(Hanon et al., 2005).
The physiological responses during hydration and no hydration exercise protocols were
typical. Plasma osmolality increased from PRE in a similar manner to that seen in other studies
(Hoffman et al., 2010). There was a treatment effect in the present study which was not seen in
the work of Hoffman and colleagues (2010). As expected fluid ingestion (ET, LD and HD trials)
resulted in a lowering of plasma osmolality. No effect from the alanine-glutamine dipeptide was
noted in changes in plasma osmolality compared to ET. As might be expected, plasma glucose
concentrations increased at the outset of exercise and then remained at a constant level during the
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1 hr run. During the ET trial, plasma glucose concentrations at 60 min significantly decreased
compared to the 30 and 45 min measures. In comparison, glucose concentrations in the trials in
which the alanine-glutamine peptide was consumed (LD and HD) did not decrease at 60 min. It
is possible that this may have been indicative of the gluconeogenic effect of alanine. In a rat
model, Sumida and Donovan (1995) reported a 27% increase in gluconeogenesis from alanine
following endurance training. The participants in the present study were endurance trained and
therefore may have benefited from this adaptation, especially with the delivery of exogenous
alanine during the LD and HD trials. Hoffman et al. (2010) reported similar results and
suggested that the lack of any change in plasma glucose during the trials in which the peptide
was consumed may have been related to the gluconeogenic effect of alanine, and might have
contributed to the delay in fatigue by sparing muscle glycogen.
There were no differences in VO2 measures across the trials or between time points
throughout the 1 hr run. This was not surprising considering that the participants were
experienced runners who were running below their lactate threshold; therefore the physiologic
strain was minimal during the 1 hr run. This does however contrast to the results reported by
Fallowfield et al. (1996). They reported a significant VO2 drift during a run to exhaustion at
70% of VO2max in active adults, with the fluid replacement trial showing an even greater VO2
drift. The greater drift was attributed to enhanced fat metabolism with the ingestion of water.
As noted above, with experienced endurance athletes who had been performing 1 hr training
sessions, VO2 drift would not be expected (Ganio, Wingo, Carroll, Thomas, & Cureton, 2006).
In the present study, even during the NHY trial, there was no significant change, supporting the
evidence that this exercise protocol did not result in a significant physiological strain. This is

44

also supported by the RQ and heart rate measures seen in the present study. The cardiovascular
strain experienced during the NHY trial compared to the ET and HD trials reflects the body
water deficit experienced during the no hydration trial and is consistent the physiological effects
of dehydration (Hoffman, 2014).

Conclusions
The results from this study indicated that ingestion of the alanine-glutamine dipeptide at
either the low dose (300 mg∙500 ml-1) or high dose (1 g∙500 ml-1) during a moderate intensity run
resulted in a significant performance improvement during a subsequent run to exhaustion at 90%
of VO2peak.

The results of the study were unable to elucidate the precise mechanism that

supported this ergogenic effect, but it may be related to an enhanced electrolyte uptake by
skeletal muscle and the possible gluconeogenic effect of alanine.

1. It was hypothesized that adding the dipeptide L-Alanyl-L-Glutamine to a sport drink would
significantly increase absorption as measured by plasma glucose, electrolytes, and glutamine
during prolonged running by endurance-trained males.
This hypothesis is accepted. The sodium measure at 60 min during the HD trial was
significantly lower than the NHY and LD trials; plasma glutamine concentration during the
LD and HD trials was significantly elevated at 45 min, with the HD trial remaining elevated
at 60 min; and at 60 min, glucose dropped significantly during the ET trial and did not
during the LD or HD trials.
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2. It was hypothesized that adding the dipeptide L-Alanyl-L-Glutamine to a sport drink will
significantly reduce the cardiovascular strain as measured by oxygen consumption, heart rate,
blood pressure, and respiratory quotient during prolonged running by endurance-trained males.
This hypothesis must be rejected, there were no differences in physiological measures
between the ET trial and the LD and HD trials.

3. It was hypothesized that adding the dipeptide L-Alanyl-L-Glutamine to a sport drink will
significantly improve muscle activation patterns and neuromuscular fatigue as measured by
electromyography root mean square signals from the vastus lateralis and rectus femoris muscles
during prolonged running by endurance-trained males.
This hypothesis must be rejected, there were no differences in EMG measures of the
vastus lateralis or rectus femoris during the run to exhaustion.
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